Quality of life of older patients undergoing renal transplantation: Finding the right immunosuppressive treatment

Drugs and Aging

Volumn 31, Issue 2, 2014, Pages 103-109

  Perlman, Rachel L ^a,b   Rao, Panduranga S ^b  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; QUALITY OF LIFE; RENAL INSUFFICIENCY; RESEARCH DESIGN; TACROLIMUS;

EID: 84894068855     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-013-0149-x     Document Type: Review

References (33)

1. Tonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011;11(10):2093-109.
2. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725-30.
3. Butt Z, Yount SE, Caicedo JC, Abecassis MM, Cella D. Quality of life assessment in renal transplant: review and future directions. Clin Transplant. 2008;22(3):292-303.
4. Molnar-Varga M, Molnar MZ, Szeifert L, Kovacs AZ, Kelemen A, Becze A, et al. Health-related quality of life and clinical outcomes in kidney transplant recipients. Am J Kidney Dis. 2011;58(3):444-52.
5. Rao PS, Schaubel DE, Wei G, Fenton SS. Evaluating the survival benefit of kidney retransplantation. Transplantation. 2006;82(5):669-74.
6. U.S. Renal Data System, USRDS 2012 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2012. http://www.usrds.org/2012/pdf/v2-ch1-12.pdf. Accessed 1 Feb 2013.
7. OPTN/SRTR 2011 annual data report. HHS/HRSA/HSB/DOT. http://srtr. transplant.hrsa.gov/annual-reports/2011/pdf/01-kidney-12.pdf. Accessed 1 Feb 2013.
8. Danovitch G, Savransky E. Challenges in the counseling and management of older kidney transplant candidates. Am J Kidney Dis. 2006;47(4 Suppl 2):S86-97.
9. Sayegh MH, Carpenter CB. Transplantation 50 years later-progress, challenges, and promises. N Engl J Med. 2004;351(26):2761-6.
10. Huang E, Poommipanit N, Sampaio MS, Kuo HT, Reddy P, Gritsch HA, et al. Intermediate-term outcomes associated with kidney transplantation in recipients 80 years and older: an analysis of the OPTN/UNOS database. Transplantation. 2010;90(9):974-9.
11. Rosner M, Abdel-Rahman E, Williams ME. Geriatric nephrology: responding to a growing challenge. Clin J Am Soc Nephrol. 2010;5(5):936-42.
12. Fiebiger W, Mitterbauer C, Oberbauer R. Health-related quality of life outcomes after kidney transplantation. Health Qual Life Outcomes. 2004;2:2.
13. Hathaway D, Winsett R, Prendergast M, Subaiya I. The first report from the patient outcomes registry for transplant effects on life (PORTEL): differences in side-effects and quality of life by organ type, time since transplant and immunosuppressive regimens. Clin Transplant. 2003;17(3):183-94.
14. Jofre R, Lopez-Gomez JM, Moreno F, Sanz-Guajardo D, Valderrabano F. Changes in quality of life after renal transplantation. Am J Kidney Dis. 1998;32(1):93-100.
15. Rebollo P, Ortega F, Baltar JM, Diaz-Corte C, Navascues RA, Naves M, et al. Health-related quality of life (HRQOL) in end stage renal disease (ESRD) patients over 65 years. Geriatr Nephrol Urol. 1998;8(2):85-94.
16. Humar A, Denny R, Matas AJ, Najarian JS. Graft and quality of life outcomes in older recipients of a kidney transplant. Exp Clin Transplant. 2003;1(2):69-72.
17. Cetingok M, Winsett RP, Hathaway DK. A comparative study of quality of life among the age groups of kidney transplant recipients. Prog Transplant. 2004;14(1):33-8.
18. Liu H, Feurer ID, Dwyer K, Speroff T, Shaffer D, Wright Pinson C. The effects of gender and age on health-related quality of life following kidney transplantation. J Clin Nurs. 2008;17(1):82-9.
19. Cornella C, Brustia M, Lazzarich E, Cofano F, Ceruso A, Barbe MC, et al. Quality of life in renal transplant patients over 60 years of age. Transplant Proc. 2008;40(6):1865-6.
20. Rosenberger J, van Dijk JP, Nagyova I, Roland R, Geckova AM, van den Heuvel WJ, et al. Do dialysis- and transplantation-related medical factors affect perceived health status? Nephrol Dial Transplant. 2005;20(10):2153-8.
21. Rebollo P, Ortega F, Baltar JM, Alvarez-Ude F, Alvarez Navascues R, Alvarez-Grande J. Is the loss of health-related quality of life during renal replacement therapy lower in elderly patients than in younger patients? Nephrol Dial Transplant. 2001;16(8):1675-80.
22. Oppenheimer F, Rebollo P, Grinyo JM, Ortega F, Sanchez-Plumed J, Gonzalez-Molina M, et al. Health-related quality of life of patients receiving low-toxicity immunosuppressive regimens: a substudy of the Symphony Study. Transplantation. 2009;87(8):1210-3.
23. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med. 2004;351(26):2715-29.
24. De Geest S, Moons P. The patient's appraisal of side-effects: the blind spot in quality-of-life assessments in transplant recipients. Nephrol Dial Transplant. 2000;15(4):457-9.
25. Falck P, Asberg A, Byberg KT, Bremer S, Bergan S, Reubsaet JL, et al. Reduced elimination of cyclosporine A in elderly (>65 years) kidney transplant recipients. Transplantation. 2008;86(10):1379-83.
26. Meier-Kriesche HU, Kaplan B. Immunosuppression in elderly renal transplant recipients: are current regimens too aggressive? Drugs Aging. 2001;18(10):751-9.
27. Reimer J, Franke GH, Philipp T, Heemann U. Quality of life in kidney recipients: comparison of tacrolimus and cyclosporine-microemulsion. Clin Transplant. 2002;16(1):48-54.
28. Bohlke M, Rocha M, Gomes RH, Marini SS, Terhorst L, Barcellos FC, et al. Tacrolimus and quality of life after kidney transplantation-a multicenter study. Clin Transplant. 2006;20(4):504-8.
29. Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Vos PF, et al. Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. Am J Transplant. 2004;4(6):937-45.
30. Moons P, Vanrenterghem Y, van Hooff JP, Squifflet JP, Margodt D, Mullens M, et al. Steroids may compromise quality of life of renal transplant recipients on a tacrolimus-based regimen. Transplant Proc. 2002;34(5):1691-2.
31. Oberbauer R, Hutchison B, Eris J, Arias M, Claesson K, Mota A, et al. Health-related quality-of-life outcomes of sirolimus-treated kidney transplant patients after elimination of cyclosporine A: results of a 2-year randomized clinical trial. Transplantation. 2003;75(8):1277-85.
32. Meier-Kriesche HU, Friedman G, Jacobs M, Mulgaonkar S, Vaghela M, Kaplan B. Infectious complications in geriatric renal transplant patients: comparison of two immunosuppressive protocols. Transplantation. 1999;68(10):1496-502.
33. Meier-Kriesche HU, Ojo A, Hanson J, Cibrik D, Lake K, Agodoa LY, et al. Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation. 2000;69(5):885-9.